Integral Ad Science (IAS) Stock Forecast, Price Target & Predictions
IAS Stock Forecast
Integral Ad Science stock forecast is as follows: an average price target of $15.88 (represents a 45.29% upside from IAS’s last price of $10.93) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
IAS Price Target
IAS Analyst Ratings
Integral Ad Science Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 06, 2024 | Brian Pitz | BMO Capital | $16.00 | $11.48 | 39.37% | 46.39% |
Aug 05, 2024 | Raimo Lenschow | Barclays | $13.00 | $11.33 | 14.74% | 18.94% |
May 24, 2024 | Youssef Squali | Truist Financial | $18.00 | $9.82 | 83.30% | 64.68% |
May 10, 2024 | Andrew Marok | Raymond James | $13.00 | $9.13 | 42.39% | 18.94% |
Apr 29, 2024 | Rob Sanderson | Loop Capital Markets | $15.00 | $9.79 | 53.22% | 37.24% |
Apr 16, 2024 | Matthew Cost | Morgan Stanley | $12.00 | $9.54 | 25.79% | 9.79% |
Jun 14, 2023 | Jason Helfstein | Oppenheimer | $25.00 | $18.88 | 32.42% | 128.73% |
Aug 15, 2022 | Brent Thill | Jefferies | $15.00 | $10.45 | 43.54% | 37.24% |
Aug 08, 2022 | - | Oppenheimer | $15.00 | $9.02 | 66.30% | 37.24% |
Jul 26, 2022 | - | Raymond James | $18.00 | $9.42 | 91.08% | 64.68% |
Integral Ad Science Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 2 | 6 |
Avg Price Target | $16.00 | $14.50 | $14.50 |
Last Closing Price | $10.93 | $10.93 | $10.93 |
Upside/Downside | 46.39% | 32.66% | 32.66% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 06, 2024 | BMO Capital | Outperform | Outperform | Hold |
Aug 05, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Aug 02, 2024 | Raymond James | Outperform | Outperform | Hold |
Jul 23, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
May 10, 2024 | Raymond James | Outperform | Outperform | Hold |
Apr 29, 2024 | Loop Capital Markets | - | Buy | Initialise |
Apr 16, 2024 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
Feb 28, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Feb 28, 2024 | Barclays | - | Overweight | Upgrade |
Feb 28, 2024 | Needham | Buy | Buy | Hold |
Integral Ad Science Financial Forecast
Integral Ad Science Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $134.29M | $120.33M | - | $106.09M | $117.44M | $101.34M | - | $89.24M | $102.47M | $79.01M | $75.08M |
Avg Forecast | $207.05M | $179.89M | $167.48M | $151.89M | $178.77M | $156.56M | $148.79M | $134.42M | $159.47M | $138.08M | $126.28M | $112.12M | $131.27M | $113.25M | $112.41M | $102.92M | $111.33M | $99.86M | $97.60M | $85.17M | $95.07M | $75.46M | $70.72M |
High Forecast | $208.39M | $181.04M | $168.56M | $152.87M | $179.92M | $157.56M | $149.75M | $135.29M | $160.49M | $138.54M | $127.10M | $112.85M | $132.20M | $113.98M | $113.14M | $103.58M | $112.05M | $100.50M | $97.60M | $88.14M | $98.39M | $78.09M | $73.19M |
Low Forecast | $206.42M | $179.34M | $166.97M | $151.43M | $178.22M | $156.08M | $148.33M | $134.01M | $158.98M | $137.84M | $125.90M | $111.78M | $130.68M | $112.90M | $112.07M | $102.61M | $110.99M | $99.55M | $97.60M | $81.81M | $91.32M | $72.48M | $67.93M |
# Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 8 | 6 | 5 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.06% | - | 1.03% | 1.05% | 1.01% | - | 1.05% | 1.08% | 1.05% | 1.06% |
Integral Ad Science EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 8 | 6 | 5 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $18.41M | $-22.67M | - | $21.90M | $21.37M | $21.35M | - | $15.87M | $15.05M | $11.18M | $-18.34M |
Avg Forecast | $35.12M | $30.51M | $28.40M | $25.76M | $30.32M | $26.55M | $25.23M | $22.80M | $27.05M | $23.42M | $21.42M | $19.02M | $22.26M | $19.21M | $19.07M | $17.46M | $18.88M | $15.80M | $16.55M | $32.13M | $16.12M | $14.37M | $-104.53M |
High Forecast | $35.34M | $30.71M | $28.59M | $25.93M | $30.51M | $26.72M | $25.40M | $22.94M | $27.22M | $23.50M | $21.56M | $19.14M | $22.42M | $19.33M | $19.19M | $17.57M | $19.00M | $18.97M | $16.55M | $38.56M | $16.69M | $17.24M | $-83.62M |
Low Forecast | $35.01M | $30.42M | $28.32M | $25.68M | $30.23M | $26.47M | $25.16M | $22.73M | $26.96M | $23.38M | $21.35M | $18.96M | $22.16M | $19.15M | $19.01M | $17.40M | $18.82M | $12.64M | $16.55M | $25.71M | $15.49M | $11.49M | $-125.43M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | -1.18% | - | 1.25% | 1.13% | 1.35% | - | 0.49% | 0.93% | 0.78% | 0.18% |
Integral Ad Science Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 8 | 6 | 5 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $10.16M | $-13.75M | - | $3.15M | $11.49M | $767.00K | - | $1.16M | $-4.82M | $-9.78M | $-35.06M |
Avg Forecast | $26.63M | $11.00M | $11.78M | $4.83M | $23.41M | $13.28M | $11.91M | $5.82M | $16.57M | $11.54M | $3.92M | $-2.06M | $6.68M | $116.26K | $3.57M | $1.46M | $1.87M | $-13.83M | $2.50M | $2.35M | $-2.56M | $-12.57M | $-199.86M |
High Forecast | $26.85M | $11.09M | $11.87M | $4.87M | $23.61M | $13.39M | $12.01M | $5.87M | $16.71M | $12.98M | $3.95M | $-2.05M | $20.04M | $117.23K | $3.60M | $1.47M | $1.89M | $-11.07M | $2.50M | $2.82M | $-2.43M | $-10.06M | $-159.89M |
Low Forecast | $26.53M | $10.96M | $11.73M | $4.81M | $23.32M | $13.23M | $11.87M | $5.80M | $16.51M | $8.65M | $3.90M | $-2.08M | $-15.59M | $115.80K | $3.56M | $1.45M | $1.86M | $-16.60M | $2.50M | $1.88M | $-2.68M | $-15.09M | $-239.83M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.52% | -118.26% | - | 2.16% | 6.14% | -0.06% | - | 0.49% | 1.88% | 0.78% | 0.18% |
Integral Ad Science SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 8 | 6 | 5 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $56.38M | $52.22M | - | $46.98M | $51.90M | $48.34M | - | $39.83M | $44.98M | $35.66M | $60.31M |
Avg Forecast | $96.96M | $84.24M | $78.43M | $71.13M | $83.71M | $73.31M | $69.67M | $62.95M | $74.67M | $64.66M | $59.13M | $52.50M | $61.47M | $53.03M | $52.64M | $48.20M | $52.13M | $50.44M | $45.71M | $80.65M | $44.52M | $45.85M | $33.12M |
High Forecast | $97.58M | $84.78M | $78.93M | $71.59M | $84.25M | $73.78M | $70.12M | $63.35M | $75.16M | $64.88M | $59.52M | $52.84M | $61.91M | $53.37M | $52.98M | $48.51M | $52.47M | $60.53M | $45.71M | $96.78M | $46.07M | $55.02M | $34.27M |
Low Forecast | $96.66M | $83.98M | $78.19M | $70.91M | $83.46M | $73.09M | $69.46M | $62.75M | $74.45M | $64.55M | $58.96M | $52.34M | $61.20M | $52.87M | $52.48M | $48.05M | $51.97M | $40.35M | $45.71M | $64.52M | $42.76M | $36.68M | $31.81M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.98% | - | 0.97% | 1.00% | 0.96% | - | 0.49% | 1.01% | 0.78% | 1.82% |
Integral Ad Science EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 8 | 6 | 5 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.06 | $-0.09 | - | $0.02 | $0.07 | - | - | $0.01 | $-0.03 | $-0.06 | $-0.26 |
Avg Forecast | $0.16 | $0.07 | $0.07 | $0.03 | $0.14 | $0.08 | $0.07 | $0.04 | $0.10 | $0.07 | $0.02 | $-0.01 | $0.04 | - | $0.02 | $0.01 | $0.01 | $-0.00 | $0.02 | $-0.04 | $-0.02 | $-0.06 | $-0.04 |
High Forecast | $0.16 | $0.07 | $0.07 | $0.03 | $0.14 | $0.08 | $0.07 | $0.04 | $0.10 | $0.08 | $0.02 | $-0.01 | $0.12 | - | $0.02 | $0.01 | $0.01 | $-0.00 | $0.02 | $-0.04 | $-0.01 | $-0.05 | $-0.04 |
Low Forecast | $0.16 | $0.07 | $0.07 | $0.03 | $0.14 | $0.08 | $0.07 | $0.04 | $0.10 | $0.05 | $0.02 | $-0.01 | $-0.10 | - | $0.02 | $0.01 | $0.01 | $-0.00 | $0.02 | $-0.04 | $-0.02 | $-0.06 | $-0.04 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.53% | -123.24% | - | 2.25% | 6.12% | -3.43% | - | -0.24% | 2.02% | 1.05% | 6.93% |
Integral Ad Science Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
WPP | WPP | $48.68 | $1.23K | 2426.71% | Buy |
IPG | Interpublic Group of Companies | $30.85 | $48.17 | 56.14% | Buy |
IAS | Integral Ad Science | $10.93 | $15.88 | 45.29% | Buy |
CMPR | Cimpress | $82.60 | $120.00 | 45.28% | - |
CTV | Innovid | $1.81 | $2.50 | 38.12% | Buy |
DLX | Deluxe | $19.84 | $27.00 | 36.09% | Buy |
OMC | Omnicom Group | $99.97 | $115.92 | 15.95% | Buy |
CRTO | Criteo | $43.50 | $48.25 | 10.92% | Buy |
TZOO | Travelzoo | $14.92 | $12.00 | -19.57% | Buy |
IAS Forecast FAQ
Is Integral Ad Science a good buy?
Yes, according to 11 Wall Street analysts, Integral Ad Science (IAS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 81.82% of IAS's total ratings.
What is IAS's price target?
Integral Ad Science (IAS) average price target is $15.88 with a range of $12 to $25, implying a 45.29% from its last price of $10.93. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Integral Ad Science stock go up soon?
According to Wall Street analysts' prediction for IAS stock, the company can go up by 45.29% (from the last price of $10.93 to the average price target of $15.88), up by 128.73% based on the highest stock price target, and up by 9.79% based on the lowest stock price target.
Can Integral Ad Science stock reach $20?
IAS's highest twelve months analyst stock price target of $25 supports the claim that Integral Ad Science can reach $20 in the near future.
What is Integral Ad Science's current price target trend?
1 Wall Street analyst forecast a $16 price target for Integral Ad Science (IAS) this month, up 46.39% from its last price of $10.93. Compared to the last 3 and 12 months, the average price target increased by 32.66% and increased by 32.66%, respectively.
What are Integral Ad Science's analysts' financial forecasts?
Integral Ad Science's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $618.53M (high $622.51M, low $616.65M), average EBITDA is $104.9M (high $105.58M, low $104.58M), average net income is $54.43M (high $54.89M, low $54.22M), average SG&A $289.64M (high $291.51M, low $288.76M), and average EPS is $0.332 (high $0.335, low $0.331). IAS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $706.31M (high $710.86M, low $704.16M), average EBITDA is $119.79M (high $120.56M, low $119.43M), average net income is $54.24M (high $54.7M, low $54.03M), average SG&A $330.75M (high $332.88M, low $329.74M), and average EPS is $0.331 (high $0.334, low $0.33).
Did the IAS's actual financial results beat the analysts' financial forecasts?
Based on Integral Ad Science's last annual report (Dec 2023), the company's revenue was $474.37M, beating the average analysts forecast of $459.85M by 3.16%. Apple's EBITDA was $52.35M, missing the average prediction of $77.99M by -32.88%. The company's net income was $7.24M, missing the average estimation of $11.83M by -38.80%. Apple's SG&A was $229.62M, beating the average forecast of $215.34M by 6.63%. Lastly, the company's EPS was $0.0448, missing the average prediction of $0.0722 by -37.97%. In terms of the last quarterly report (Dec 2023), Integral Ad Science's revenue was $134.3M, beating the average analysts' forecast of $131.27M by 2.30%. The company's EBITDA was $18.41M, missing the average prediction of $22.26M by -17.31%. Integral Ad Science's net income was $10.16M, beating the average estimation of $6.68M by 52.12%. The company's SG&A was $56.38M, missing the average forecast of $61.47M by -8.28%. Lastly, the company's EPS was $0.0623, beating the average prediction of $0.0408 by 52.68%